BI 764524: Sema3A antibody Phase 2Indication: Diabetic Retinopathy (DR) This compound is under investigation, further information will be available soon. Partner enquiries Join our team Additional Links Read more Our Science: Retinal Health Read more Read more Complications of Diabetic Retinopathy Read more